BPC-157 + TB-500 (Fragment 17-24) Blend

100% delivery

  • Done Satisfaction Guaranteed
  • Done No Hassle Refunds
  • Done Secure Payments
GUARANTEED SAFE CHECKOUT
  • Visa Card
  • MasterCard
SKU: bpc-10mg-tb-10mg-fragment-17-24 Category:

Description

For Research Use Only. Not for Human or Veterinary Use.
Recovery20mg*10vialsHPLC ≥ 99%COA per batch

BPC157 10mg+TB500 (Fragment 17-24) 10mg

Specifications:
COA for BPC 10mg + TB 10mg (Fragment 17-24) not yet published

Contact us for current batch testing data on this specification.

TL;DR

BPC157 10mg+TB500 (Fragment 17-24) 10mg is a dual-peptide research formulation combining BPC-157 and Thymosin Beta-4 Fragment 17–24 in a balanced 1:1 ratio.

Overview

Each vial contains 10 mg of BPC-157 and 10 mg of Thymosin Beta-4 Fragment 17–24, providing 20 mg of total peptide content in a lyophilized formulation.

Peptide Combination

Combining BPC-157 with Thymosin Beta-4 Fragment 17–24, this formulation provides a convenient option for peptide-related laboratory research.

Key Highlights

  • Dual-Peptide Formula — Combines BPC-157 and TB Fragment 17–24.
  • Lyophilized Format — Convenient format for laboratory research.
  • Triple-receptor agonist GLP-1R/GIPR/GCGR
  • Lyophilized solid peptide,good stability
  • Third-party tested, research-grade raw material

Safety & Side Effects

BPC157 10mg+TB500 (Fragment 17-24) 10mg is a dual-peptide research formulation combining BPC-157 and Thymosin Beta-4 Fragment 17–24 in a balanced 1:1 ratio. When used in research, BPC 10mg + TB 10mg (Fragment 17-24) should be handled in a qualified laboratory setting, and its safety profile should be interpreted strictly within the experimental context in which it was studied.

Published bpc 10mg + tb 10mg (fragment 17-24) side effects data are limited to experimental models and are specific to the dose, route, and study design employed. Investigators should account for tissue repair and recovery readouts and any off-target effects relevant to the compound’s mechanism when designing a study.

For authoritative safety and toxicology references, consult peer-reviewed databases (PubMed, PubChem) and review the batch Certificate of Analysis before designing your protocol.

Dosage & Protocol

There is no standardized human dosage for BPC 10mg + TB 10mg (Fragment 17-24); it is supplied strictly for laboratory research. Reported bpc 10mg + tb 10mg (fragment 17-24) dosage values in the literature are derived from preclinical studies and are specific to the study model, route, and experimental design.

Research protocols typically document bpc 10mg + tb 10mg (fragment 17-24) dosage together with reconstitution method, storage conditions, and analytical confirmation of identity (CAS 137525-51-0 (BPC-157); N/A (TB Fragment 17–24), molecular formula C62H98N16O22 (BPC-157); C38H67N13O16 (TB Fragment 17–24), molecular weight 1419.5 g/mol (BPC-157); ~969.0 g/mol (TB Fragment 17–24)). Because dose-response relationships may not scale across models, investigators should base their design on peer-reviewed methods rather than informal community reports.

Always confirm the exact strength, purity, and lot-specific data from the batch COA before weighing or reconstituting your sample.

How to Order

1

Enquiry

Send strength and quantity for a quote.

2

Quotation

Price,lead time and specification confirmed.

3

QC &COA

HPLC/LC-MS tested; COA issued.

4

Delivery

Tracked worldwide shipping.

Specifications

Product name BPC157 10mg+TB500 (Fragment 17-24) 10mg
Product code BBF20
Specification 20mg*10vials
CAS number 137525-51-0 (BPC-157); N/A (TB Fragment 17–24)
Molecular formula C62H98N16O22 (BPC-157); C38H67N13O16 (TB Fragment 17–24)
Molecular weight 1419.5 g/mol (BPC-157); ~969.0 g/mol (TB Fragment 17–24)
Purity ≥99% (subject to batch COA)

Applications

ResearchLaboratoryAcademicDrug Discovery

Packaging & Shipping

Available pack sizes

20mg*10vials

Shipping

WorldwideCold ChainExpress

Storage & Handling

Store lyophilized material at −20°C, protected from light and moisture. Avoid repeated temperature fluctuations and freeze–thaw cycles.

Product Information Q&A

1. What is BPC157 10mg+TB500 (Fragment 17-24) 10mg?

BPC157 10mg+TB500 (Fragment 17-24) 10mg is a dual-peptide research formulation combining BPC-157 and Thymosin Beta-4 Fragment 17–24.

2. What peptides are included in this formulation?

Each vial contains 10 mg of BPC-157 and 10 mg of Thymosin Beta-4 Fragment 17–24.

3. What is the total peptide content?

The formulation contains 20 mg of total peptide material per vial, with 10 mg of each peptide.